calidibio.com - Bathi operasional EBITDA CLDI
The development of Calidi Biotherapeutics (CLDI) relies on viral cell delivery and FDA approval. Demand for cancer immunotherapy remains stable, ensuring the business's macro-resilience. The company strictly adheres to bio-waste ethics and laboratory energy conservation. The absolute operating profit reflects smoothed cash flow dynamics, where the current status equals 0.00, masking potential capital expenditures.
Calidi Biotherapeutics, Inc. (CLDI) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Rasio Total Utang marang Ekuitas Calidi Biotherapeutics|CLDI - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Calidi Biotherapeutics Inc.|CLDI - Utang perusahaan|Rasio utang marang kapitalisasi buku Calidi Biotherapeutics|CLDI - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Calidi Biotherapeutics|Rasio likuiditas darurat calidibio.com
- statistik bathi lan rasio pasar:
CLDI - Bathi resik|Prakiraan bathi perusahaan Calidi Biotherapeutics|CLDI - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Calidi Biotherapeutics Inc.|CLDI - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Calidi Biotherapeutics|CLDI - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Calidi Biotherapeutics|CLDI - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan calidibio.com|CLDI - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Calidi Biotherapeutics
Analisis kabeh metrik perusahaan:Calidi Biotherapeutics (CLDI)
The absence of current sales and high development costs for oncology platforms make Calidi Biotherapeutics (CLDI) dependent on external financing. This EBITDA result captures the company's real-time cash flows from core operations, eliminating accounting assumptions and allowing investors to assess the business's current financial resilience to external shocks without quarterly delays.
Karo sapa Calidi Biotherapeutics saingan
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi operasional EBITDA PSNL|Bathi operasional sadurunge ngurangi amortisasi erasca.com ERAS|Bathi operasional EBITDA DCTH (Delcath Systems)|Bathi operasional EBITDA Y-mAbs Therapeutics Inc YMAB|AURA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CADL: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|ARAY: Bathi operasional EBITDA|SLS - Pendapatan operasional sadurunge ngurangi amortisasi|ACTU (Actuate Therapeutics) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi CTOR (Citius Oncology Inc.)|Bathi operasional EBITDA HURA|Pendapatan operasional sadurunge ngurangi amortisasi Protara Tx|Fate Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi WHWK|TScan - Bathi operasional EBITDA|CSBR: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|XBIT: Bathi operasional EBITDA|CVM - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OS Therapies Incorporated|Bathi sadurunge bunga, pajak, lan amortisasi radiopharmtheranostics.com RADX|Bathi operasional sadurunge ngurangi amortisasi ARTV (Artiva Biotherapeutics, Inc.)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi ANL|Bathi operasional EBITDA VERU (Veru Pharma)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TPST|Xilio - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Renovaro Inc.|muraloncology.com (MURA) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Kairos Pharma - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|OKUR (OnKure Therapeutics, Inc.) - Bathi operasional EBITDA|Bathi operasional EBITDA CytoMed|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Curis, Inc. (CRIS)|APLM: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA THAR (Tharimmune)|Advanced Biomed Inc. (ADVB) - Bathi sadurunge bunga, pajak, lan amortisasi|GNPX: Bathi operasional sadurunge ngurangi amortisasi|SBFM - Bathi operasional EBITDA|XBIO (xeneticbio.com) - Bathi operasional sadurunge ngurangi amortisasi|SLRX: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|PPBT (Purple Biotech Ltd.) - Bathi operasional EBITDA|AON (AONC) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA BGNE|Bathi operasional sadurunge ngurangi amortisasi Checkpoint Therapeutics Inc CKPT|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Elevation Oncology ELEV|Pendapatan operasional sadurunge ngurangi amortisasi iCAD Inc. (ICAD)|Ikena - Bathi operasional EBITDA|Notable Labs Ltd (NTBL) - Bathi operasional sadurunge ngurangi amortisasi|viracta.com (VIRX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MOR (MorphoSys Corporation) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|NAYA (NAYA Biosciences) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi AAPGV (ascentage.com)
